Stock Information

Symbol Market Last Change Volume

View Stock Information

Latest Webcast

Cancer Genetics, Inc. is an emerging leader in DNA-based cancer diagnostics and services some of the most prestigious medical institutions in the world. Our tests target cancers that are difficult to diagnose and predict treatment outcomes. These cancers include hematological, urogenital and HPV-associated cancers. We also offer a comprehensive range of non-proprietary oncology-focused tests and laboratory services that provide critical genomic information to healthcare professionals as well as biopharma and biotech. We have established strong research collaborations with major cancer centers such as Memorial Sloan-Kettering, The Cleveland Clinic, Mayo Clinic and the National Cancer Institute. For further information, please see www.cancergenetics.com.

Latest Press Releases

  • Jan17

    Precision Oncology Diagnostics Leader, Cancer Genetics, Inc. & Precision Therapeutics Company, Lantern Pharma, Inc. Announce Strategic Collaboration Focused on Drug Rescue & Repurposing Leveraging Genomics, Biomarkers & Artificial Intelligence Driven Development for Multiple Lead Oncology Compounds Read More

  • Jan09

    Cancer Genetics, Inc. Announces Multiple Agreements & Collaborations to Develop Liquid Biopsy Programs with Leading Biopharma Companies Read More

  • Jan06

    Cancer Genetics, Inc. Announces Consolidation and Cost Reduction in Administrative and Operational Support Functions Read More

Latest Events

  • Nov10

    3rd Quarter 2016 Conference Call
    Date: November 10, 2016

  • Nov02

    Companion Diagnostics (CDx) Symposium
    Date: November 2-3, 2016
    Location: Edison, NJ
    Read More

  • Oct20

    Dawson James Securities Growth Stock Conference
    Date: October 20, 2016
    Location: Jupiter, Florida


Cancer Genetics, Inc.
201 Route 17 North
2nd Floor
Rutherford, NJ 07070

Investor Relations
Cancer Genetics, Inc.
Panna Sharma

Discover Cancer Genetics Incorporated »

Our Research
With unparalleled excellence in oncology, our team is dedicated to empowering personalized cancer treatment.
Our Media
Stay current with the latest company news, articles, videos, and webinars.
Our Partners
CGI has established strong research collaborations with key thought leaders in oncology and major cancer centers in the U.S. and abroad.
Click here to login and view your reports.